APO Research
Talk to an analyst

APO RESEARCH · REPORT

Computational Toxicology Platform

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Computational Toxicology Platform Market Analysis and Forecast 2026-2032

12 August 2026171 pages

Choose your research edition.

Industry ResearchComputational Toxicology Platform Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Computational Toxicology Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Computational Toxicology Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computational Toxicology Platform Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Computational Toxicology Platform Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global Computational Toxicology Platform market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Computational Toxicology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Computational Toxicology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Computational Toxicology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Computational Toxicology Platform is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Computational Toxicology Platform include Simulations Plus, Lhasa, Instem, Elsevier, Clarivate, ACD/Labs, Optibrium, MultiCASE and Chemical Computing Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Computational Toxicology Platform, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Computational Toxicology Platform, also provides the revenue of main regions and countries. Of the upcoming market potential for Computational Toxicology Platform, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Computational Toxicology Platform revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Computational Toxicology Platform market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Computational Toxicology Platform revenue, projected growth trends, production technology, application and end-user industry.

Computational Toxicology Platform Segment by Company

Simulations Plus

Lhasa

Instem

Elsevier

Clarivate

ACD/Labs

Optibrium

MultiCASE

Chemical Computing Group

Molecular Networks

ProtoQSAR

KREATiS

Certara

Dassault Systèmes

Schrödinger

Computational Toxicology Platform Segment by Type

Cloud-Based Platform

On-Premises Software

Hybrid Deployment

Computational Toxicology Platform Segment by Application

Pharmaceutical and Biotechnology

Chemicals and Materials

Agrochemicals

Cosmetics and Consumer Products

Government and Regulatory Agencies

Academic and Contract Research

Computational Toxicology Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computational Toxicology Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computational Toxicology Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computational Toxicology Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Computational Toxicology Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Computational Toxicology Platform company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computational Toxicology Platform revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Computational Toxicology Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-Based Platform Major Player Table 3. On-Premises Software Major Player Table 4. Hybrid Deployment Major Player Table 5. Global Computational Toxicology Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Pharmaceutical and Biotechnology Major Player Table 7. Chemicals and Materials Major Player Table 8. Agrochemicals Major Player Table 9. Cosmetics and Consumer Products Major Player Table 10. Government and Regulatory Agencies Major Player Table 11. Academic and Contract Research Major Player Table 12. Computational Toxicology Platform Industry Trends Table 13. Computational Toxicology Platform Industry Drivers Table 14. Computational Toxicology Platform Industry Opportunities and Challenges Table 15. Computational Toxicology Platform Industry Restraints Table 16. Global Computational Toxicology Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Computational Toxicology Platform Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Computational Toxicology Platform Market Share by Region (2021-2026) Table 19. Global Computational Toxicology Platform Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Computational Toxicology Platform Market Share by Region (2027-2032) Table 21. Global Computational Toxicology Platform Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Computational Toxicology Platform Revenue Market Share by Players (2021-2026) Table 23. Global Computational Toxicology Platform Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Computational Toxicology Platform Key Players Headquarters & Area Served Table 25. Global Computational Toxicology Platform Players, Product Type & Application Table 26. Global Computational Toxicology Platform Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Computational Toxicology Platform by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Computational Toxicology Platform Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Computational Toxicology Platform Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Computational Toxicology Platform Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Computational Toxicology Platform Revenue Market Share by Type (2021-2026) Table 33. Global Computational Toxicology Platform Revenue Market Share by Type (2027-2032) Table 34. Global Computational Toxicology Platform Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Computational Toxicology Platform Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Computational Toxicology Platform Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Computational Toxicology Platform Revenue Market Share by Application (2021-2026) Table 38. Global Computational Toxicology Platform Revenue Market Share by Application (2027-2032) Table 39. Simulations Plus Company Information Table 40. Simulations Plus Business Overview Table 41. Simulations Plus Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Simulations Plus Computational Toxicology Platform Product Portfolio Table 43. Simulations Plus Recent Development Table 44. Lhasa Company Information Table 45. Lhasa Business Overview Table 46. Lhasa Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Lhasa Computational Toxicology Platform Product Portfolio Table 48. Lhasa Recent Development Table 49. Instem Company Information Table 50. Instem Business Overview Table 51. Instem Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Instem Computational Toxicology Platform Product Portfolio Table 53. Instem Recent Development Table 54. Elsevier Company Information Table 55. Elsevier Business Overview Table 56. Elsevier Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Elsevier Computational Toxicology Platform Product Portfolio Table 58. Elsevier Recent Development Table 59. Clarivate Company Information Table 60. Clarivate Business Overview Table 61. Clarivate Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Clarivate Computational Toxicology Platform Product Portfolio Table 63. Clarivate Recent Development Table 64. ACD/Labs Company Information Table 65. ACD/Labs Business Overview Table 66. ACD/Labs Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. ACD/Labs Computational Toxicology Platform Product Portfolio Table 68. ACD/Labs Recent Development Table 69. Optibrium Company Information Table 70. Optibrium Business Overview Table 71. Optibrium Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Optibrium Computational Toxicology Platform Product Portfolio Table 73. Optibrium Recent Development Table 74. MultiCASE Company Information Table 75. MultiCASE Business Overview Table 76. MultiCASE Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. MultiCASE Computational Toxicology Platform Product Portfolio Table 78. MultiCASE Recent Development Table 79. Chemical Computing Group Company Information Table 80. Chemical Computing Group Business Overview Table 81. Chemical Computing Group Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Chemical Computing Group Computational Toxicology Platform Product Portfolio Table 83. Chemical Computing Group Recent Development Table 84. Molecular Networks Company Information Table 85. Molecular Networks Business Overview Table 86. Molecular Networks Computational Toxicology Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Molecular Networks Computational Toxicology Platform Product Portfolio Table 88. Molecular Networks Recent Development Table 89. ProtoQSAR Company Information Table 90. ProtoQSAR Business Overview Table 91. ProtoQSAR Computational Toxicology Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. ProtoQSAR Computational Toxicology Platform Product Portfolio Table 93. ProtoQSAR Recent Development Table 94. KREATiS Company Information Table 95. KREATiS Business Overview Table 96. KREATiS Computational Toxicology Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. KREATiS Computational Toxicology Platform Product Portfolio Table 98. KREATiS Recent Development Table 99. Certara Company Information Table 100. Certara Business Overview Table 101. Certara Computational Toxicology Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Certara Computational Toxicology Platform Product Portfolio Table 103. Certara Recent Development Table 104. Dassault Systèmes Company Information Table 105. Dassault Systèmes Business Overview Table 106. Dassault Systèmes Computational Toxicology Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Dassault Systèmes Computational Toxicology Platform Product Portfolio Table 108. Dassault Systèmes Recent Development Table 109. Schrödinger Company Information Table 110. Schrödinger Business Overview Table 111. Schrödinger Computational Toxicology Platform Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Schrödinger Computational Toxicology Platform Product Portfolio Table 113. Schrödinger Recent Development Table 114. North America Computational Toxicology Platform Revenue by Type (2021-2026) & (US$ Million) Table 115. North America Computational Toxicology Platform Revenue by Type (2027-2032) & (US$ Million) Table 116. North America Computational Toxicology Platform Revenue by Application (2021-2026) & (US$ Million) Table 117. North America Computational Toxicology Platform Revenue by Application (2027-2032) & (US$ Million) Table 118. North America Computational Toxicology Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Computational Toxicology Platform Revenue by Country (2021-2026) & (US$ Million) Table 120. North America Computational Toxicology Platform Revenue by Country (US$ Million) & (2027-2032) Table 121. Europe Computational Toxicology Platform Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Computational Toxicology Platform Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Computational Toxicology Platform Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Computational Toxicology Platform Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Computational Toxicology Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Computational Toxicology Platform Revenue by Country (2021-2026) & (US$ Million) Table 127. Europe Computational Toxicology Platform Revenue by Country (US$ Million) & (2027-2032) Table 128. China Computational Toxicology Platform Revenue by Type (2021-2026) & (US$ Million) Table 129. China Computational Toxicology Platform Revenue by Type (2027-2032) & (US$ Million) Table 130. China Computational Toxicology Platform Revenue by Application (2021-2026) & (US$ Million) Table 131. China Computational Toxicology Platform Revenue by Application (2027-2032) & (US$ Million) Table 132. Asia Computational Toxicology Platform Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Computational Toxicology Platform Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Computational Toxicology Platform Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Computational Toxicology Platform Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Computational Toxicology Platform Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Computational Toxicology Platform Revenue by Region (US$ Million) & (2021-2026) Table 138. Asia Computational Toxicology Platform Revenue by Region (US$ Million) & (2027-2032) Table 139. SAMEA Computational Toxicology Platform Revenue by Type (2021-2026) & (US$ Million) Table 140. SAMEA Computational Toxicology Platform Revenue by Type (2027-2032) & (US$ Million) Table 141. SAMEA Computational Toxicology Platform Revenue by Application (2021-2026) & (US$ Million) Table 142. SAMEA Computational Toxicology Platform Revenue by Application (2027-2032) & (US$ Million) Table 143. SAMEA Computational Toxicology Platform Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. SAMEA Computational Toxicology Platform Revenue by Country (2021-2026) & (US$ Million) Table 145. SAMEA Computational Toxicology Platform Revenue by Country (US$ Million) & (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Computational Toxicology Platform Image Figure 2. Global Computational Toxicology Platform Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computational Toxicology Platform Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-Based Platform Image Figure 5. On-Premises Software Image Figure 6. Hybrid Deployment Image Figure 7. Global Computational Toxicology Platform Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Computational Toxicology Platform Market Size Share 2021 VS 2025 VS 2032 Figure 9. Pharmaceutical and Biotechnology Image Figure 10. Chemicals and Materials Image Figure 11. Agrochemicals Image Figure 12. Cosmetics and Consumer Products Image Figure 13. Government and Regulatory Agencies Image Figure 14. Academic and Contract Research Image Figure 15. Global Computational Toxicology Platform Market Size (US$ Million) & (2021-2032) Figure 16. Global Computational Toxicology Platform Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Computational Toxicology Platform Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Computational Toxicology Platform Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Computational Toxicology Platform Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Computational Toxicology Platform Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Computational Toxicology Platform Revenue Market Share by Type (2021-2032) Figure 23. Global Computational Toxicology Platform Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Computational Toxicology Platform Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Computational Toxicology Platform Revenue Market Share by Application (2021-2032) Figure 26. North America Computational Toxicology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Computational Toxicology Platform Revenue Share by Type (2021-2032) Figure 28. North America Computational Toxicology Platform Revenue Share by Application (2021-2032) Figure 29. North America Computational Toxicology Platform Revenue Share by Country (2021-2032) Figure 30. United States Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Computational Toxicology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Computational Toxicology Platform Revenue Share by Type (2021-2032) Figure 35. Europe Computational Toxicology Platform Revenue Share by Application (2021-2032) Figure 36. Europe Computational Toxicology Platform Revenue Share by Country (2021-2032) Figure 37. Germany Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Computational Toxicology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Computational Toxicology Platform Revenue Share by Type (2021-2032) Figure 47. China Computational Toxicology Platform Revenue Share by Application (2021-2032) Figure 48. Asia Computational Toxicology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Computational Toxicology Platform Revenue Share by Type (2021-2032) Figure 50. Asia Computational Toxicology Platform Revenue Share by Application (2021-2032) Figure 51. Asia Computational Toxicology Platform Revenue Share by Region (2021-2032) Figure 52. Japan Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Computational Toxicology Platform Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Computational Toxicology Platform Revenue Share by Type (2021-2032) Figure 60. SAMEA Computational Toxicology Platform Revenue Share by Application (2021-2032) Figure 61. SAMEA Computational Toxicology Platform Revenue Share by Country (2021-2032) Figure 62. Brazil Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Computational Toxicology Platform Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based Platform
  • On-Premises Software
  • Hybrid Deployment
Applications
  • Pharmaceutical and Biotechnology
  • Chemicals and Materials
  • Agrochemicals
  • Cosmetics and Consumer Products
  • Government and Regulatory Agencies
  • Academic and Contract Research
Companies covered
  • Simulations Plus
  • Lhasa
  • Instem
  • Elsevier
  • Clarivate
  • ACD/Labs
  • Optibrium
  • MultiCASE
  • Chemical Computing Group
  • Molecular Networks
  • ProtoQSAR
  • KREATiS
  • Certara
  • Dassault Systèmes
  • Schrödinger

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Computational Toxicology Platform Market by Type
  3. 1.2.1 Global Computational Toxicology Platform Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-Based Platform
  5. 1.2.3 On-Premises Software
  6. 1.2.4 Hybrid Deployment
  7. 1.3 Computational Toxicology Platform Market by Application
  8. 1.3.1 Global Computational Toxicology Platform Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Pharmaceutical and Biotechnology
  10. 1.3.3 Chemicals and Materials
  11. 1.3.4 Agrochemicals
  12. 1.3.5 Cosmetics and Consumer Products
  13. 1.3.6 Government and Regulatory Agencies
  14. 1.3.7 Academic and Contract Research
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Computational Toxicology Platform Market Dynamics
  1. 2.1 Computational Toxicology Platform Industry Trends
  2. 2.2 Computational Toxicology Platform Industry Drivers
  3. 2.3 Computational Toxicology Platform Industry Opportunities and Challenges
  4. 2.4 Computational Toxicology Platform Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Computational Toxicology Platform Market Perspective (2021-2032)
  2. 3.2 Global Computational Toxicology Platform Growth Trends by Region
  3. 3.2.1 Global Computational Toxicology Platform Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Computational Toxicology Platform Market Size by Region (2021-2026)
  5. 3.2.3 Global Computational Toxicology Platform Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Computational Toxicology Platform Revenue by Players
  2. 4.1.1 Global Computational Toxicology Platform Revenue by Players (2021-2026)
  3. 4.1.2 Global Computational Toxicology Platform Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Computational Toxicology Platform Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Computational Toxicology Platform Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Computational Toxicology Platform Key Players Headquarters & Area Served
  7. 4.4 Global Computational Toxicology Platform Players, Product Type & Application
  8. 4.5 Global Computational Toxicology Platform Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Computational Toxicology Platform Market CR5 and HHI
  11. 4.6.3 2025 Computational Toxicology Platform Tier 1, Tier 2, and Tier 3
5 Computational Toxicology Platform Market Size by Type
  1. 5.1 Global Computational Toxicology Platform Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Computational Toxicology Platform Revenue by Type (2021-2032)
  3. 5.3 Global Computational Toxicology Platform Revenue Market Share by Type (2021-2032)
6 Computational Toxicology Platform Market Size by Application
  1. 6.1 Global Computational Toxicology Platform Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Computational Toxicology Platform Revenue by Application (2021-2032)
  3. 6.3 Global Computational Toxicology Platform Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Simulations Plus
  2. 7.1.1 Simulations Plus Company Information
  3. 7.1.2 Simulations Plus Business Overview
  4. 7.1.3 Simulations Plus Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Simulations Plus Computational Toxicology Platform Product Portfolio
  6. 7.1.5 Simulations Plus Recent Developments
  7. 7.2 Lhasa
  8. 7.2.1 Lhasa Company Information
  9. 7.2.2 Lhasa Business Overview
  10. 7.2.3 Lhasa Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lhasa Computational Toxicology Platform Product Portfolio
  12. 7.2.5 Lhasa Recent Developments
  13. 7.3 Instem
  14. 7.3.1 Instem Company Information
  15. 7.3.2 Instem Business Overview
  16. 7.3.3 Instem Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Instem Computational Toxicology Platform Product Portfolio
  18. 7.3.5 Instem Recent Developments
  19. 7.4 Elsevier
  20. 7.4.1 Elsevier Company Information
  21. 7.4.2 Elsevier Business Overview
  22. 7.4.3 Elsevier Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Elsevier Computational Toxicology Platform Product Portfolio
  24. 7.4.5 Elsevier Recent Developments
  25. 7.5 Clarivate
  26. 7.5.1 Clarivate Company Information
  27. 7.5.2 Clarivate Business Overview
  28. 7.5.3 Clarivate Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Clarivate Computational Toxicology Platform Product Portfolio
  30. 7.5.5 Clarivate Recent Developments
  31. 7.6 ACD/Labs
  32. 7.6.1 ACD/Labs Company Information
  33. 7.6.2 ACD/Labs Business Overview
  34. 7.6.3 ACD/Labs Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ACD/Labs Computational Toxicology Platform Product Portfolio
  36. 7.6.5 ACD/Labs Recent Developments
  37. 7.7 Optibrium
  38. 7.7.1 Optibrium Company Information
  39. 7.7.2 Optibrium Business Overview
  40. 7.7.3 Optibrium Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Optibrium Computational Toxicology Platform Product Portfolio
  42. 7.7.5 Optibrium Recent Developments
  43. 7.8 MultiCASE
  44. 7.8.1 MultiCASE Company Information
  45. 7.8.2 MultiCASE Business Overview
  46. 7.8.3 MultiCASE Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  47. 7.8.4 MultiCASE Computational Toxicology Platform Product Portfolio
  48. 7.8.5 MultiCASE Recent Developments
  49. 7.9 Chemical Computing Group
  50. 7.9.1 Chemical Computing Group Company Information
  51. 7.9.2 Chemical Computing Group Business Overview
  52. 7.9.3 Chemical Computing Group Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Chemical Computing Group Computational Toxicology Platform Product Portfolio
  54. 7.9.5 Chemical Computing Group Recent Developments
  55. 7.10 Molecular Networks
  56. 7.10.1 Molecular Networks Company Information
  57. 7.10.2 Molecular Networks Business Overview
  58. 7.10.3 Molecular Networks Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Molecular Networks Computational Toxicology Platform Product Portfolio
  60. 7.10.5 Molecular Networks Recent Developments
  61. 7.11 ProtoQSAR
  62. 7.11.1 ProtoQSAR Company Information
  63. 7.11.2 ProtoQSAR Business Overview
  64. 7.11.3 ProtoQSAR Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ProtoQSAR Computational Toxicology Platform Product Portfolio
  66. 7.11.5 ProtoQSAR Recent Developments
  67. 7.12 KREATiS
  68. 7.12.1 KREATiS Company Information
  69. 7.12.2 KREATiS Business Overview
  70. 7.12.3 KREATiS Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  71. 7.12.4 KREATiS Computational Toxicology Platform Product Portfolio
  72. 7.12.5 KREATiS Recent Developments
  73. 7.13 Certara
  74. 7.13.1 Certara Company Information
  75. 7.13.2 Certara Business Overview
  76. 7.13.3 Certara Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Certara Computational Toxicology Platform Product Portfolio
  78. 7.13.5 Certara Recent Developments
  79. 7.14 Dassault Systèmes
  80. 7.14.1 Dassault Systèmes Company Information
  81. 7.14.2 Dassault Systèmes Business Overview
  82. 7.14.3 Dassault Systèmes Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Dassault Systèmes Computational Toxicology Platform Product Portfolio
  84. 7.14.5 Dassault Systèmes Recent Developments
  85. 7.15 Schrödinger
  86. 7.15.1 Schrödinger Company Information
  87. 7.15.2 Schrödinger Business Overview
  88. 7.15.3 Schrödinger Computational Toxicology Platform Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Schrödinger Computational Toxicology Platform Product Portfolio
  90. 7.15.5 Schrödinger Recent Developments
8 North America
  1. 8.1 North America Computational Toxicology Platform Revenue (2021-2032)
  2. 8.2 North America Computational Toxicology Platform Revenue by Type (2021-2032)
  3. 8.2.1 North America Computational Toxicology Platform Revenue by Type (2021-2026)
  4. 8.2.2 North America Computational Toxicology Platform Revenue by Type (2027-2032)
  5. 8.3 North America Computational Toxicology Platform Revenue Share by Type (2021-2032)
  6. 8.4 North America Computational Toxicology Platform Revenue by Application (2021-2032)
  7. 8.4.1 North America Computational Toxicology Platform Revenue by Application (2021-2026)
  8. 8.4.2 North America Computational Toxicology Platform Revenue by Application (2027-2032)
  9. 8.5 North America Computational Toxicology Platform Revenue Share by Application (2021-2032)
  10. 8.6 North America Computational Toxicology Platform Revenue by Country
  11. 8.6.1 North America Computational Toxicology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Computational Toxicology Platform Revenue by Country (2021-2026)
  13. 8.6.3 North America Computational Toxicology Platform Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Computational Toxicology Platform Revenue (2021-2032)
  2. 9.2 Europe Computational Toxicology Platform Revenue by Type (2021-2032)
  3. 9.2.1 Europe Computational Toxicology Platform Revenue by Type (2021-2026)
  4. 9.2.2 Europe Computational Toxicology Platform Revenue by Type (2027-2032)
  5. 9.3 Europe Computational Toxicology Platform Revenue Share by Type (2021-2032)
  6. 9.4 Europe Computational Toxicology Platform Revenue by Application (2021-2032)
  7. 9.4.1 Europe Computational Toxicology Platform Revenue by Application (2021-2026)
  8. 9.4.2 Europe Computational Toxicology Platform Revenue by Application (2027-2032)
  9. 9.5 Europe Computational Toxicology Platform Revenue Share by Application (2021-2032)
  10. 9.6 Europe Computational Toxicology Platform Revenue by Country
  11. 9.6.1 Europe Computational Toxicology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Computational Toxicology Platform Revenue by Country (2021-2026)
  13. 9.6.3 Europe Computational Toxicology Platform Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Computational Toxicology Platform Revenue (2021-2032)
  2. 10.2 China Computational Toxicology Platform Revenue by Type (2021-2032)
  3. 10.2.1 China Computational Toxicology Platform Revenue by Type (2021-2026)
  4. 10.2.2 China Computational Toxicology Platform Revenue by Type (2027-2032)
  5. 10.3 China Computational Toxicology Platform Revenue Share by Type (2021-2032)
  6. 10.4 China Computational Toxicology Platform Revenue by Application (2021-2032)
  7. 10.4.1 China Computational Toxicology Platform Revenue by Application (2021-2026)
  8. 10.4.2 China Computational Toxicology Platform Revenue by Application (2027-2032)
  9. 10.5 China Computational Toxicology Platform Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Computational Toxicology Platform Revenue (2021-2032)
  2. 11.2 Asia Computational Toxicology Platform Revenue by Type (2021-2032)
  3. 11.2.1 Asia Computational Toxicology Platform Revenue by Type (2021-2026)
  4. 11.2.2 Asia Computational Toxicology Platform Revenue by Type (2027-2032)
  5. 11.3 Asia Computational Toxicology Platform Revenue Share by Type (2021-2032)
  6. 11.4 Asia Computational Toxicology Platform Revenue by Application (2021-2032)
  7. 11.4.1 Asia Computational Toxicology Platform Revenue by Application (2021-2026)
  8. 11.4.2 Asia Computational Toxicology Platform Revenue by Application (2027-2032)
  9. 11.5 Asia Computational Toxicology Platform Revenue Share by Application (2021-2032)
  10. 11.6 Asia Computational Toxicology Platform Revenue by Country
  11. 11.6.1 Asia Computational Toxicology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Computational Toxicology Platform Revenue by Country (2021-2026)
  13. 11.6.3 Asia Computational Toxicology Platform Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Computational Toxicology Platform Revenue (2021-2032)
  2. 12.2 SAMEA Computational Toxicology Platform Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Computational Toxicology Platform Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Computational Toxicology Platform Revenue by Type (2027-2032)
  5. 12.3 SAMEA Computational Toxicology Platform Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Computational Toxicology Platform Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Computational Toxicology Platform Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Computational Toxicology Platform Revenue by Application (2027-2032)
  9. 12.5 SAMEA Computational Toxicology Platform Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Computational Toxicology Platform Revenue by Country
  11. 12.6.1 SAMEA Computational Toxicology Platform Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Computational Toxicology Platform Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Computational Toxicology Platform Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst